Projects per year
Personal profile
Biography
Graduated from the University of Cambridge in 2012 including an intercalated degree in Pharmacology (1st). He then undertook a Respiratroy Academic Foundation Job affiliated with the University of East Anglia and NHS Norfolk and Norwich. During these 2 years he obtained his MRCP(UK).
Following his Foundation Years, Mark worked for a year in Canberra, Australia. He obtained registration with the Australian Medical Council and retains registration. He returned to Scotland to undertake Core Medical Training, including a rotation at the Beatson West of Scotland Cancer Centre.
He began Specialty training in Medical Oncology in 2017 before taking up a SCREDS Clinical Lectureship with Prof Petty at the University of Dundee. He obtained CSO funding to undertake a 3 year PhD focussed on frailty in advanced gastroesophageal cancer and began this in August 2020.
Research
CSO Clinical Academic Fellow
Vice chairman of NOTCH (National Oncology Trainee Collaborative for Healthcare Research)
Research interests
Frailty in advanced cancer
Biomarkers for chemosensitivity
Supportive care
Quality of life
Education/Academic qualification
PGCert THE
Award Date: 1 May 2018
Doctor of Medicine, University of Cambridge
Award Date: 27 Jun 2012
Bachelor of Arts, University of Cambridge
1 Oct 2006 → 30 Jun 2009
Award Date: 30 Jun 2009
External positions
Medical Oncology Registrar, NHS Tayside
10 Sep 2018 → …Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- Frailty
- Geriatric Oncology
- Toxicity
- Gastric cancer
- Oesophageal cancer
Fingerprint
Dive into the research topics where Mark Baxter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
Establishing DNA Damage Response-Deficient (DDRD) Status in Patients with Advanced Oesophageal Adenocarcinoma who have had an Exceptional Response to First Line Chemotherapy
Baxter, M., Petty, R. & Walsh, S.
1/03/19 → 31/08/19
Project: Research
Research output
-
Acute renal transplant rejection following nivolumab therapy for metastatic melanoma
Tan, B., Baxter, M. & Casasola, R., 8 Feb 2021, In: BMJ Case Reports. 14, 2, 6 p., e238037.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Perspectives on geriatric oncology research presented at the 2020 ESMO Science Congress
Baxter, M. A. J., Madureira, T., Haase, K. & Battisti, N. M. L., 1 Apr 2021, In: Journal of Geriatric Oncology. 12, 3, p. 489-497 9 p.Research output: Contribution to journal › Article › peer-review
-
Real‑world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review)
Baxter, M. A., Petty, R. D., Swinson, D., Hall, P. S. & O'Hanlon, S., May 2021, In: International Journal of Oncology. 58, 5, p. 1-13 13 p., 22.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The impact of COVID-19 on systemic anticancer treatment delivery in Scotland
Baxter, M. A., Murphy, J., Cameron, D., Jordan, J., Crearie, C., Lilley, C., Sadoyze, A., Maclean, M., Hall, P., Phillips, A., Greger, A., Madeleine, J. & Petty, R. D., 12 Apr 2021, In: British Journal of Cancer. 124, p. 1353-1356 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
1690P Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19
Lee, R., Zhou, C., Shotton, R., Tivey, A., Dickens, E., Huddar, P., Mckenzie, H., Boyce, H., Maynard, A., Rowe, M. P., Khan, S., Eastlake, L., Angelakas, A., Baxter, M., Copson, E., Horsley, L., Thomas, A., Wilson, C., Cooksley, T. & Armstrong, A., Sep 2020, In: Annals of Oncology. 31, Supplement 4, p. S999 1 p.Research output: Contribution to journal › Meeting abstract › peer-review